CRC
ALLO icon

Curi RMB Capital’s Allogene Therapeutics ALLO Stock Holding History

Curi RMB Capital’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-195,890
Closed -$286K – 662
2025
Q1 		$286K Buy
195,890
+46,313
+31% +$87.3K 0.01% 439
2024
Q4 		$319K Hold
149,577
– – 0.01% 454
2024
Q3 		$419K Buy
149,577
+48,202
+48% +$128K 0.01% 450
2024
Q2 		$236K Hold
101,375
– – 0.01% 501
2024
Q1 		$453K Buy
101,375
+27,560
+37% +$115K 0.01% 447
2023
Q4 		$237K Hold
73,815
– – 0.01% 475
2023
Q3 		$234K Buy
73,815
+34,980
+90% +$153K 0.01% 460
2023
Q2 		$193K Hold
38,835
– – 0.01% 496
2023
Q1 		$192K Buy
38,835
+9,856
+34% +$63.2K 0.01% 475
2022
Q4 		$182K Buy
28,979
+10,750
+59% +$99.5K 0.01% 458
2022
Q3 		$197K Hold
18,229
– – 0.01% 457
2022
Q2 		$208K Hold
18,229
– – 0.01% 453
2022
Q1 		$166K Hold
18,229
– – 0.01% 432
2021
Q4 		$272K Hold
18,229
– – 0.01% 415
2021
Q3 		$468K Hold
18,229
– – 0.02% 351
2021
Q2 		$475K Hold
18,229
– – 0.02% 359
2021
Q1 		$643K Hold
18,229
– – 0.02% 319
2020
Q4 		$460K Hold
18,229
– – 0.02% 440
2020
Q3 		$687K Sell
18,229
-2,657
-13% -$100K 0.03% 368
2020
Q2 		$894K Sell
20,886
-1,720
-8% -$62.2K 0.04% 313
2020
Q1 		$439K Buy
22,606
+141
+0.6% +$3.36K 0.02% 420
2019
Q4 		$584K Hold
22,465
– – 0.02% 428
2019
Q3 		$612K Hold
22,465
– – 0.02% 458
2019
Q2 		$603K Buy
+22,465
New +$626K 0.02% 508

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Curi RMB Capital's ALLO Position: Q2 2025 in Review

Curi RMB Capital sold out of Allogene Therapeutics (ALLO) in Q2 2025, closing a stake of 195,890 shares — an estimated $286K sold.

Curi RMB Capital first reported a position in ALLO in Q2 2019 and held it in 24 quarters. The position peaked at $894K in Q2 2020. 158 funds tracked by Wall St. Rank hold ALLO as of Q2 2025.

  • Curi RMB Capital reported no remaining Allogene Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Curi RMB Capital sold 195,890 Allogene Therapeutics shares in Q2 2025, an estimated $286K.
  • Curi RMB Capital first reported a position in Allogene Therapeutics in Q2 2019 and held it in 24 quarters.
  • Curi RMB Capital's Allogene Therapeutics position peaked at $894K in Q2 2020.
  • 158 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2025.

Based on Curi RMB Capital's 13F filing for Q2 2025, filed 14 Aug 2025.